Alpha Centric Advisors LLC Charles River Laboratories International, Inc. Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 1,474 shares of CRL stock, worth $252,112. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,474Holding current value
$252,112% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.05 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$870 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$697 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$373 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$309 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...